Research has shown that the microbial metabolite TMA can directly block the immune protein IRAK4, leading to reduced inflammation and improved insulin sensitivity. This molecule protects against the negative effects of high-fat diets while providing protection to mice against sepsis. IRAK4 is a known drug target, suggesting that the discovered mechanism could lead to new treatment approaches in diabetes. The study highlights the importance of the cooperation between gut microbes and nutrition in maintaining metabolic health. The research does not provide specific statistics, but confirms that TMA has a significant anti-inflammatory and anti-diabetic effect. This discovery supports the idea that changes in the gut microbiota can significantly influence the course of diabetes. The results are important for the further development of therapies aimed at immune and metabolic processes.